870-P: Empagliflozin and the Risk of Gout—Analysis from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
TESFAYE, HELEN, PAIK, JULIE M., ZABOTKA, LUKE, HTOO, PHYO T., SCHMEDT, NIKLAS, KOENEMAN, LISETTE, SEMAN, LEO J., WEXLER, DEBORAH J., PATORNO, ELISABETTA
Published in Diabetes (New York, N.Y.) (20.06.2023)
Published in Diabetes (New York, N.Y.) (20.06.2023)
Get full text
Journal Article
103-LB: Impact of Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i) and Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in COVID-19 Patients with Preexisting Type 2 Diabetes (T2D) and Cardiovascular Disease (CVD)
NGUYEN, CHI, CROWE, CHRISTOPHER L., KUTI, EFFIE, DONATO, BONNIE M.K., DJARAHER, RACHEL L., SEMAN, LEO J., GRAETER, NANCY, POWER, THOMAS P., WILLEY, VINCENT
Published in Diabetes (New York, N.Y.) (20.06.2023)
Published in Diabetes (New York, N.Y.) (20.06.2023)
Get full text
Journal Article
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Empagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Healthy Japanese Subjects
Sarashina, Akiko, Koiwai, Kazuki, Seman, Leo J., Yamamura, Norio, Taniguchi, Atsushi, Negishi, Takahiro, Sesoko, Shogo, Woerle, Hans J., Dugi, Klaus A.
Published in DRUG METABOLISM AND PHARMACOKINETICS (2013)
Published in DRUG METABOLISM AND PHARMACOKINETICS (2013)
Get full text
Journal Article
163-LB: Impact of Preexisting Type 2 Diabetes (T2D) and Concurrent Cardiovascular Disease (CVD) on Patients with COVID-19 (C-19)
NGUYEN, CHI, CROWE, CHRISTOPHER, KUTI, EFFIE, NARSIPUR, NIHAL, DONATO, BONNIE M.K., PEPE, REBECCA S., DJARAHER, RACHEL L., SEMAN, LEO J., GRAETER, NANCY, POWER, THOMAS P., MEHRA, RINKU, WILLEY, VINCENT
Published in Diabetes (New York, N.Y.) (01.06.2022)
Published in Diabetes (New York, N.Y.) (01.06.2022)
Get full text
Journal Article
Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
Lamon-Fava, Stefania, Marcovina, Santica M., Albers, John J., Kennedy, Hal, DeLuca, Carl, White, Charles C., Cupples, L. Adrienne, McNamara, Judith R., Seman, Leo J., Bongard, Vanina, Schaefer, Ernst J.
Published in Journal of lipid research (01.06.2011)
Published in Journal of lipid research (01.06.2011)
Get full text
Journal Article
Empagliflozin (BI 10773), a Potent and Selective SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
Seman, Leo, Macha, Sreeraj, Nehmiz, Gerhard, Simons, Gudrun, Ren, Bailuo, Pinnetti, Sabine, Woerle, Hans J, Dugi, Klaus
Published in Clinical pharmacology in drug development (01.04.2013)
Published in Clinical pharmacology in drug development (01.04.2013)
Get more information
Journal Article
Heart failure documentation in outpatients with diabetes and volume overload: an observational cohort study from the Diabetes Collaborative Registry
Arnold, Suzanne V, Jones, Philip G, Beasley, Michael, Cordova, Jeanine, Goyal, Abhinav, Fonarow, Gregg C, Seman, Leo
Published in Cardiovascular diabetology (12.12.2020)
Published in Cardiovascular diabetology (12.12.2020)
Get full text
Journal Article
Impact of Pre-existing Type 2 Diabetes Mellitus and Cardiovascular Disease on Healthcare Resource Utilization and Costs in Patients With COVID-19
Nguyen, Chi, Crowe, Christopher L, Kuti, Effie, Donato, Bonnie, Djaraher, Rachel, Seman, Leo, Graeter, Nancy, Power, Thomas P, Mehra, Rinku, Willey, Vincent J
Published in Journal of health economics and outcomes research (Online) (2024)
Published in Journal of health economics and outcomes research (Online) (2024)
Get full text
Journal Article
Exposure−response modelling for empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in patients with type 2 diabetes
Riggs, Matthew M., Seman, Leo J., Staab, Alexander, MacGregor, Thomas R., Gillespie, William, Gastonguay, Marc R., Woerle, Hans J., Macha, Sreeraj
Published in British journal of clinical pharmacology (01.12.2014)
Published in British journal of clinical pharmacology (01.12.2014)
Get full text
Journal Article
Pharmacokinetics of empagliflozin, a sodium glucose cotransporter-2 (SGLT2) inhibitor, and metformin following co-administration in healthy volunteers
Macha, Sreeraj, Dieterich, Sabine, Mattheus, Michaela, Seman, Leo J, Broedl, Uli C, Woerle, Hans J
Published in International journal of clinical pharmacology and therapeutics (01.02.2013)
Published in International journal of clinical pharmacology and therapeutics (01.02.2013)
Get more information
Journal Article
Effects of Atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein- associated phospholipase A2 in patients with coronary heart disease versus control subjects
SCHAEFER, Ernst J, MCNAMARA, Judith R, ASZTALOS, Bela F, TAYLER, Timothy, DALY, Jennifer A, GLEASON, Joi L, SEMAN, Leo J, FERRARI, Andrea, RUBENSTEIN, Joel J
Published in The American journal of cardiology (01.05.2005)
Published in The American journal of cardiology (01.05.2005)
Get full text
Journal Article
Comparisons of effects of statins ( atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects
Schaefer, Ernst J, McNamara, Judith R, Tayler, Timothy, Daly, Jennifer A, Gleason, Joi L, Seman, Leo J, Ferrari, Andrea, Rubenstein, Joel J
Published in The American journal of cardiology (2004)
Published in The American journal of cardiology (2004)
Get full text
Journal Article
Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects
Schaefer, Ernst J, McNamara, Judith R, Tayler, Timothy, Daly, Jennifer A, Gleason, Joi A, Seman, Leo J, Ferrari, Andrea, Rubenstein, Joel J
Published in The American journal of cardiology (01.10.2002)
Published in The American journal of cardiology (01.10.2002)
Get full text
Journal Article
Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease
Schaefer, Ernst J, Audelin, Marie C, McNamara, Judith R, Shah, Paulesh K, Tayler, Timothy, Daly, Jennifer A, Augustin, Joi L, Seman, Leo J, Rubenstein, Joel J
Published in The American journal of cardiology (15.11.2001)
Published in The American journal of cardiology (15.11.2001)
Get full text
Journal Article
The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings
Jenner, Jennifer L., Seman, Leo J., Millar, John S., Lamon-Fava, Stefania, Welty, Francine K., Dolnikowski, Gregory G., Marcovina, Santica M., Lichtenstein, Alice H., Barrett, P. Hugh R., deLuca, Carl, Schaefer, Ernst J.
Published in Metabolism, clinical and experimental (01.03.2005)
Published in Metabolism, clinical and experimental (01.03.2005)
Get full text
Journal Article
Lipoprotein(a)-Cholesterol and Coronary Heart Disease in the Framingham Heart Study
Seman, Leo J, DeLuca, Carl, Jenner, Jennifer L, Cupples, L. Adrienne, McNamara, Judith R, Wilson, Peter W.F, Castelli, William P, Ordovas, Jose M, Schaefer, Ernst J
Published in Clinical chemistry (Baltimore, Md.) (01.07.1999)
Published in Clinical chemistry (Baltimore, Md.) (01.07.1999)
Get full text
Journal Article
Antihyperglycemic and Blood Pressure Effects of Empagliflozin in Black Patients With Type 2 Diabetes Mellitus and Hypertension
Ferdinand, Keith C, Izzo, Joseph L, Lee, Jisoo, Meng, Leslie, George, Jyothis, Salsali, Afshin, Seman, Leo
Published in Circulation (New York, N.Y.) (30.04.2019)
Published in Circulation (New York, N.Y.) (30.04.2019)
Get full text
Journal Article
Empagliflozin Use and the Risk of Nephrolithiasis in Patients With Type 2 Diabetes: SA-PO259
Paik, Julie M., Tesfaye, Helen, Zakoul, Heidi, Schmedt, Niklas, Koeneman, Lisette, Seman, Leo, Curhan, Gary C., Wexler, Deborah J., Patorno, Elisabetta
Published in Journal of the American Society of Nephrology (01.11.2022)
Published in Journal of the American Society of Nephrology (01.11.2022)
Get full text
Journal Article